Cosmetic uses of botulinum toxins for lower aspects of the face and neck

Clinics in Dermatology

Volumn 22, Issue 1, 2004, Pages 18-22

  Lowe, Nicholas J ^a   Yamauchi, Paul ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; NEURO BLOC;

DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG STORAGE; DYSPHASIA; DYSPHONIA; DYSTONIA; FACE; FACE MUSCLE; HUMAN; HYPERHIDROSIS; MUSCLE RELAXATION; MUSCLE WEAKNESS; NECK; NONHUMAN; PLATYSMA MUSCLE; PRIORITY JOURNAL; REJUVENATION; REVIEW; STORAGE TEMPERATURE; SURGICAL TECHNIQUE;

EID: 2442705140     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2003.12.025     Document Type: Article

References (17)

1. Matarasso A., Matarasso S.L., Brandt F.S., Bellman B. Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg. 103:1999;645-652
2. Kane M.A. Nonsurgical treatment of platysmal bands with injection of botulinum toxin A. Plast Reconstr Surg. 103:1999;656-665
3. Brandt F., Bellman A. Cosmetic use of botulinum A exotoxin for the ageing neck. Derm Surg. 24:1998;1232-1234
4. Lowe N.J., Maxwell A., Harper H. Botulinum exotoxin for glabellar folds a double blind placebo controlled study with an EMG injection technique. J Am Acad Dermatol. 35:1996;569-572
5. Semchysyn N., Sengelman R.D. Botulinum Toxin A treatment of perioral rhytides. Dermatol Surg. 29:2003;490-495
6. Lowe N.J., Yamauchi P.S., Lask G.P., et al. Botulinum toxins type A and B for brow furrows preliminary experiences with type B toxin dosing. J Cosmet Laser Ther. 4:2002;15-18
7. Carruthers J.A., Lowe N.J., Menter M.A., et al. A multicenter, double blind, randomised, placebo controlled study of the efficacy and safety of Botulinum toxin A in the treatment of Glabella lines. J Am Acad Dermatol. 46:2002;840-849
8. Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Opthamol 1973:1044-9
9. Blitzer A. Botulinum neurotoxin A for the management of lower facial lines and platysmal bands. Lowe N.J. Textbook of Facial Rejuvenation. 2002;171-176 Martin Dunitz/Taylor and Francis, London
10. Lowe NJ. Botulinum toxin: combination treatments for the face and neck. In: Lowe NJ (Editor). Textbook of Facial Rejuvenation. London: Martin Dunitz/Taylor and Francis. 2002: 158-70
11. Spencer JM. Cosmetic uses of Botulinum toxin type B. Cosmetic Dermatol 2002;Feb;11-4
12. Alam M., Dover J.S., Arndt K.A. Pain associated with injection of Botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative a double blind, randomised controlled trial. Archs Dermatol. 138:2002;510-514
13. Sadick N. Prospective open label study of Botulinum toxin type B (Myobloc) at doses of 2400 and 3000 U for the treatment of Glabellar lines. Dermatol Surg. 29:2003;501-507
14. Baumann L., Slezinger A., Vujevich J., et al. A double blinded, randomised, placebo controlled pilot study of the safety and efficacy of Myobloc (Botulinum Toxin type B) - purified Neurotoxin complex for the treatment of crow's feet a double-blinded placebo-controlled trial. Dermatol Surg. 29:2003;508-515
15. Carruthers J., Carruthers A. Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg. 29:2003;468-476
16. Klein A. Complications, adverse reactions and insights with the use of botulinum toxin. Dermatol Surg. 29:2003;542-556
17. Park M.Y., Ki Y.A., Duck S.J. Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg. 29:2003;477-483